Alberto Fabbri

Dr. Alberto Fabbri


Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2009 in The Lancet
Verified
Journal Article
Closed access
AFAndrés José María Ferreri
Andrés José María Ferreri
MRMichele Reni
Michele Reni
MFMarco Foppoli
Marco Foppoli
MMMaurizio Martelli
Maurizio Martelli
GPGerasimus A Pangalis
Gerasimus A Pangalis
FCFranco Cavalli
Franco Cavalli

10 April 2021 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
FMFrancesco Merli
Francesco Merli
SLStefano Luminari
Stefano Luminari
ATAlessandra Tucci
Alessandra Tucci
AAAnnalisa Arcari
Annalisa Arcari
LRLuigi Rigacci
Luigi Rigacci
MSMichele Spina
Michele Spina
PURPOSE: To prospectively validate the use of a simplified geriatric assessment (sGA) at diagnosis and to integrate it into a prognostic score for older patients with diffuse large B-cell lymphoma (DLBCL).METHODS: We conducted the prospective Elderly Project study on patients with DLBCL older than 64 years who underwent our Fondazione Italiana Linfomi original geriatric assessment (oGA) (age, Cumulative Illness Rating Scale for Geriatrics, activities of daily living, and instrumental activities of daily living) before treatment. Treatment choice was left to the physician's discretion. The primary end point was overall survival (OS) (ClinicalTrials.gov identifier: NCT02364050 ).RESULTS: We analyzed 1,163 patients (median age 76 years), with a 3-year OS of 65% (95% CI, 62 to 68). Because at multivariate analysis on oGA, age > 80 years retained an independent correlation with OS, we also developed a new, simplified version of the GA (sGA) that classifies patients as fit (55%), unfit (28%), and frail (18%) with significantly different 3-year OS of 75%, 58%, and 43%, respectively. The sGA groups, International Prognostic Index, and hemoglobin levels were independent predictors of OS and were used to build the Elderly Prognostic Index (EPI). Three risk groups were identified: low (23%), intermediate (48%), and high (29%), with an estimated 3-year OS of 87% (95% CI, 81 to 91), 69% (95% CI, 63 to 73), and 42% (95% CI, 36 to 49), respectively. The EPI was validated using an independent external series of 328 cases.CONCLUSION: The Elderly Project validates sGA as an objective tool to assess fitness status and defines the new EPI to predict OS of older patients with DLBCL.

9 October 2014 in Leukemia & Lymphoma
Verified
Journal Article
Closed access
ATAlessandra Tucci
Alessandra Tucci
MMMaurizio Martelli
Maurizio Martelli
LRLuigi Rigacci
Luigi Rigacci
PRPaola Riccomagno
Paola Riccomagno
MCMaria Giuseppina Cabras
Maria Giuseppina Cabras
F(For The Italian Lymphoma Foundation (Fil)
For The Italian Lymphoma Foundation (Fil)
We performed a multicenter study to validate the concept that a simple comprehensive geriatric assessment (CGA) can identify elderly, non-fit patients with diffuse large B-cell lymphoma (DLBCL) in whom curative treatment is not better then palliation, and to analyze potential benefits of treatment modulation after further subdividing the non-fit category by CGA criteria. One hundred and seventy-three patients aged > 69 treated with curative or palliative intent by clinical judgement only were grouped according to CGA into fit (46%), unfit (16%) and frail (38%) categories. Two-year overall survival (OS) was significantly better in fit than in non-fit patients (84% vs. 47%; p < 0.0001). Survival in unfit and frail patients was not significantly different. Curative treatment slightly improved 2-year OS in unfit (75% vs. 45%) but not in frail patients (44% vs. 39%). CGA was confirmed as very efficient in identifying elderly patients with DLBCL who can benefit from a curative approach. Further efforts are needed to better tailor therapies in non-fit patients.

27 October 2006 in Annals of Oncology
Verified
Journal Article
Open access
PDF file
LALuca Arcaini
Luca Arcaini
SBS. Burcheri
S. Burcheri
ARA. Rossi
A. Rossi
MPMarco Paulli
Marco Paulli
Raffaele BrunoRaffaele Bruno
Raffaele Bruno
MLM. Lazzarino
M. Lazzarino
Background: Hepatitis C virus (HCV) infection is frequently associated with B-cell non-Hodgkin's lymphomas. We investigated the prevalence of HCV infection in nongastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) in order to define the relationship between the viral infection and the presenting features, treatment, and outcome. Methods: We retrospectively studied 172 patients with a histological diagnosis of marginal zone B-cell lymphoma of MALT, except for stomach, and with available HCV serology, among a series of 208 patients. Results: HCV infection was documented in 60 patients (35%). Most HCV-positive patients (97%) showed a single MALT organ involvement. HCV-positive patients showed a more frequent involvement of skin (35%), salivary glands (25%), and orbit (15%). The majority of stage IV HCV-positive patients (71%) had a single MALT site with bone marrow involvement. The overall response rate was similar in HCV-positive (93%) and HCV-negative patients (87%). Overall survival (OS) and event-free survival (EFS) did not differ according to HCV infection. In multivariate analysis, advanced disease (stage III–IV) was associated with a poorer OS (P = 0.0001), irrespective of HCV serostatus. Conclusions: This study shows that nongastric marginal zone lymphomas are characterized by a high prevalence of HCV infection. Patients with involvement of a single MALT site have the highest prevalence of HCV. HCV-positive nongastric lymphomas of MALT show an indolent course similar to HCV-negative patients and seem an ideal target for exploiting the antilymphoma activity of antiviral treatments.

13 May 2011 in Journal of Oral Rehabilitation
Verified
Journal Article
Closed access
PDF file
DMDaniele Manfredini
Daniele Manfredini
AFAlberto Fabbri
Alberto Fabbri
RPR. Peretta
R. Peretta
LGL. Guarda-Nardini
L. Guarda-Nardini
FLF. Lobbezoo
F. Lobbezoo

1 April 2008 in The Lancet Oncology
Verified
Journal Article
Closed access
PZPier Luigi Zinzani
Pier Luigi Zinzani
MTMonica Tani
Monica Tani
APAlessandro Pulsoni
Alessandro Pulsoni
MGMarco Gobbi
Marco Gobbi
APAlessio Perotti
Alessio Perotti
MBMichele Baccarani
Michele Baccarani